Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 202244

Expand all

RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)
EQ 5MG BASE
Marketing Status: Discontinued

Active Ingredient: RIZATRIPTAN BENZOATE
Proprietary Name: RIZATRIPTAN BENZOATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202244
Product Number: 001
Approval Date: Dec 31, 2012
Applicant Holder Full Name: APOTEX INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)
EQ 10MG BASE
Marketing Status: Discontinued

Active Ingredient: RIZATRIPTAN BENZOATE
Proprietary Name: RIZATRIPTAN BENZOATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202244
Product Number: 002
Approval Date: Dec 31, 2012
Applicant Holder Full Name: APOTEX INC
Marketing Status:  Discontinued
Patent and Exclusivity Information